Three companies such as Tianxin Pharmaceutical increased the price of raw materials and the price of drug -raised drugs to pick up funds

The reporter learned from the State Medical Insurance Bureau that recently, the State Medical Insurance Bureau, in accordance with relevant departments, guides relevant provinces to guide relevant provinces to Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. Baiyunshan Pharmaceutical General Plant, Guangzhou Baiyunshan Mountain Three companies including Jingxiu Pharmaceutical Co., Ltd. and other three companies' drug virtual high prices and set up funds for special investigations.

After investigation, from May 2017 to May 2021, three pharmaceutical manufacturers including Tianxin Pharmaceuticals in order to avoid the "two -vote" policies and supervision, they colluded with more than 50 pharmaceutical agents in the lower reaches, and 87 types of cephalosporidumin and other 87 species of cephalosporidum sulfur were injected. The drugs were cash out by using virtual high -priced prices and transferred funds to downstream drug agents. The amount involves huge amounts, and some of them are used for bribery medical staff or specific relationship persons to carry out drug violations.

The main operation method of cash out is that pharmaceutical manufacturers signed a cooperation agreement with drug agents to increase the designated "dealers" in the procurement of the raw and drug. Double -fold sales to drug manufacturers. Pharmaceutical manufacturers further transmit the virtual high price of raw drugs to the price of factory and bidding network prices in the name of "raising price increases and high production costs". The "dealer" of the raw medicine "dealer" is actually controlled by the drug agent, and the difference in income obtained by the low -selling and high -sale and high -sale raw medicines is cash to the drug agent for medical business bribery.

Taking cephalosporin sulfur sulfur as an example, Baiyunshan Pharmaceutical (Preparation Factory) and Baiyunshan Chemical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmaceutical Pharmacea Instead, the cash -up process is set up, and the "dealer" controlled by the agent controlled by the agent will be transferred to the preparation factory at low buying high. The preparation factory uses the high price of cephalosporin sulfurizer in the cost of the raw medicine drug, which makes the drug production and circulation link on the surface and other policies and regulations to avoid supervision.

At present, three enterprises such as Tianxin Pharmaceuticals have rectified 87 kinds of drugs such as cephalosporin sulfurizes across the country as required and eliminated the virtual heights such as bribery in the current price. The product regulations were stopped purchased. Guangdong Province ordered three companies including Tianxin Pharmaceutical and other related companies to comprehensively rectify marketing models to stop relevant illegal operations. In addition, relevant departments are investigating and punishing in accordance with the law for those suspected of disciplinary, illegal, and crimes.

On August 10, Guangzhou Baiyunshan Medical Group Co., Ltd. issued the "Announcement on the State Medical Insurance Bureau's Notice". The announcement shows that the Baiyunshan Pharmaceutical General Plant of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. is its subordinate branch. Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd. and Guangzhou Baiyunshan Jingxiu Pharmaceutical Co., Ltd. are their holding subsidiaries. The announcement predicts that this matter will have a certain impact on the company's future product sales, but it will not have a significant impact on the company's operating performance.

Reporter: Xing Can

- END -